Phase I Clinical Trial of a Candidate PCV13 in Healthy People

Clinical trial NCT05602480 · UNKNOWN

Trial details

NCT number: NCT05602480
Sponsor: Wuhan BravoVax Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2022-11-01
Primary completion: 2024-06-01
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.